Embecta Corp. Reports First Quarter Fiscal 2023 Financial Results
February 14, 2023 06:30 ET
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported...
embecta Announces Quarterly Cash Dividend
February 14, 2023 06:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (NASDAQ: EMBC) have declared a quarterly cash dividend of $0.15 for each issued and...
embecta to Participate in Upcoming Investor Conferences
February 08, 2023 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will...
embecta opens new global headquarters in Parsippany, N.J.
January 25, 2023 07:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spinoff...
embecta to Report Fiscal First Quarter 2023 Financial Results
January 24, 2023 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to...
Embecta Corp. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
December 20, 2022 06:30 ET
|
Embecta Corp.
PARSIPPANY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial results for...
embecta Announces Quarterly Cash Dividend
December 20, 2022 06:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (NASDAQ: EMBC) have declared a quarterly cash dividend of $0.15 for each issued and...
embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference
December 14, 2022 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on...
Intuity Medical and embecta Launch Commercial Collaboration, Expanding Access to Self-Management Innovations for People With Diabetes
November 07, 2022 06:50 ET
|
Embecta Corp.
FREMONT, Calif. and PARSIPPANY, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Intuity Medical, Inc. and Embecta Corp. (“embecta”) (NASDAQ: EMBC) today announced they have signed a co-promotional agreement...
embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results
November 03, 2022 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to...